[b]Opko's 4KScore Could Generate Over $1.8 Billion Annually[/b]
[b][color=blue]October 3, 2012[/color][/b] | 16 comments | about: OPK,
Disclosure: I am long OPK. (More...)
I recently began accumulating shares in a promising pharmaceutical and diagnostics company, Opko Health (OPK). Opko's CEO, Pharma guru Dr. Phillip Frost, has been buying large numbers of shares for the past couple of years. Given his remarkable track record, if he is buying shares in his own company, I pay attention.
I expect a major short squeeze based on near-term catalysts described below. But the short squeeze is just icing on the cake. This company has products that are addressing at least five different billion-dollar markets. I will analyze one of those markets, prostate cancer diagnostics.